fabricated M1‐like macrophage‐derived exosome‐based PTX delivery system, which could induce potent anti‐tumor efficacy of chemotherapy, because M1‐Exos activated classical M1‐associated NF‐κB‐mediated pro‐inflammatory response in the TME.[249]. The gene discussed is NFKB1; the disease is neoplasm.